• $54,412.00
    Market Cap
  • 1,300.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
07/31/2024
07/31/2023
07/31/2022
07/31/2021
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
436
-9.92%
484
-99.65%
138,281
+362.29%
29,912
-45.29%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
1,397
+0.29%
1,393
-88.71%
12,334
-24.65%
16,370
-18.61%
Total Operating Expenses
541,975
+9.73%
493,912
-71.71%
1.7M
+85.75%
939,977
-28.70%
Operating Profit
-541,975
+9.73%
-493,912
-71.71%
-1.7M
+85.75%
-939,977
-28.70%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-144,143
+81.14%
-79,577
-20.74%
-100,402
-81.80%
-551,750
+13.13%
Interest Income and Expense and Net
-144,143
+81.14%
-79,577
-20.74%
-100,402
-81.80%
-551,750
+13.13%
Total Nonoperating Income and Expense
-269,587
-352.24%
106,876
-52.94%
227,099
-58.84%
551,750
+13.13%
Income before Taxes
-541,975
+9.73%
-493,912
-71.71%
-1.7M
+85.75%
-939,977
-28.70%
Income Taxes
8.2M
+2.11%
8.1M
+1.21%
8.0M
+3.96%
7.7M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-811,562
+109.69%
-387,036
-74.52%
-1.5M
-19.44%
-1.9M
-94.55%
Net Income from Continuing Operations Applicable to Common
-811,562
+109.69%
-387,036
-74.52%
-1.5M
-19.44%
-1.9M
-94.55%
Basic EPS and Net Income
-0.02
N/A
N/A
N/A
-0.05
-37.50%
-0.08
-33.33%
Diluted EPS and Net Income
-0.02
N/A
N/A
N/A
-0.05
-37.50%
-0.08
-33.33%
Basic Weighted Average Shares
35.7M
N/A
N/A
N/A
33.2M
+40.51%
23.7M
+42.95%
Diluted Weighted Average Shares
35.7M
N/A
N/A
N/A
33.2M
+40.51%
23.7M
+42.95%
Balance Sheet
Cash and Cash Equivalents
35
+250.00%
10
-68.75%
32
-99.99%
296,130
+584.87%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
35
+250.00%
10
-68.75%
32
-99.99%
296,130
+584.87%
Total Current Assets
35
-96.43%
980
-97.59%
40,713
-86.50%
301,546
+597.39%
Accumulated Depreciation
N/A
N/A
87,632
0.00%
87,632
+12.13%
78,152
+18.08%
Property and Plant and Equipment and Net
N/A
N/A
0
N/A
0
-100.00%
9,480
-55.80%
Total Long-Term Assets
N/A
N/A
0
N/A
0
-100.00%
9,480
-55.80%
Total Assets
10,648
-18.03%
12,990
-93.72%
206,901
-56.90%
480,068
+462.50%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
601,028
+734.76%
72,000
-88.02%
601,028
+314.19%
145,108
-17.95%
Total Current Liabilities
3.8M
+18.29%
3.2M
+0.19%
3.2M
+12.58%
2.9M
+53.29%
Total Long-Term Debt
706,789
+17.60%
601,028
0.00%
601,028
+7.07%
561,346
+83.98%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
1.0M
+18.83%
Total Liabilities
3.8M
+18.29%
3.2M
+0.19%
3.2M
+12.58%
2.9M
+53.29%
Retained Earnings
-39.2M
+2.11%
-38.4M
+1.02%
-38.0M
+4.16%
-36.5M
+5.46%
Total Stockholders Equity
-3.8M
+14.86%
-3.3M
+6.43%
-3.1M
+25.54%
-2.5M
+39.28%
Total Shares Outstanding
40.3M
+17.92%
34.1M
+0.75%
33.9M
+15.72%
29.3M
+36.46%
Cash Flow
Cash from Operating Activities
-183,273
+114.53%
-85,432
-79.61%
-418,917
+7.84%
-388,477
-33.92%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
N/A
0
+100.00%
-152,785
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
183,298
+114.61%
85,410
-30.46%
122,819
-84.53%
794,153
+153.22%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-6,866.59%
+1,850.59%
-352.03%
-20.39%
-442.21%
-33.69%
-666.93%
-94.17%
Return on Equity
22.82%
+89.29%
12.06%
-77.82%
54.37%
-38.63%
88.60%
-96.77%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.00
-100.00%
0.0003
-97.64%
0.01
-87.96%
0.11
+354.74%
Cash Ratio
0.00
N/A
0.00
N/A
0.00
-100.00%
0.10
+346.55%
Debt-to-Equity Ratio
-0.34
+69.21%
-0.20
-47.40%
-0.39
+35.52%
-0.29
+5.24%
Debt-to-Assets Ratio
122.82
+137.06%
51.81
+791.79%
5.81
+294.79%
1.47
-73.94%

Earnings & Revenue History

Debt-to-Assets

Cash Flow